Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases

In the present study we evaluated how systemic arterial hypertension (SAH), dyslipidemia and diabetes mellitus influence the efficacy, safety and retention rate of biological disease-modifying anti-rheumatic drug (bDMARD) treatment in rheumatic musculoskeletal disorders (RMDs). The charts of RMD pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cometi, Laura, Bruni, Cosimo, Chiti, Nicolò, Tofani, Lorenzo, Nacci, Francesca, Bartoli, Francesca, Bellando-Randone, Silvia, Melchiorre, Daniela, Fiori, Ginevra, Guiducci, Serena, Matucci-Cerinic, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290363/
https://www.ncbi.nlm.nih.gov/pubmed/32370139
http://dx.doi.org/10.3390/jcm9051310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290363/
https://www.ncbi.nlm.nih.gov/pubmed/32370139
http://dx.doi.org/10.3390/jcm9051310

Ejemplares similares